Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis reports issuance of CRL for RLX030 by FDA
The Fly on the Wall
Fri, 05/16/14 - 07:47 am
Tags:
Novartis, RLX030, FDA, acute heart failure
Mergers seem to be a prescription for growth for pharmaceuticals
Yahoo/Market Realist
Thu, 05/15/14 - 05:59 pm
Tags:
M&A, Pfizer, GSK, Merck, Bayer, AstraZeneca, Valeant Pharmaceuticals, Novartis, Eli Lilly
Teva Loses Suit Against FDA Over Generic of Copaxone
Bloomberg
Thu, 05/15/14 - 07:35 am
Tags:
Teva, FDA, generics, Copaxone, Mylan Labs, Novartis, Sandoz, multiple sclerosis
Japanese officials: Novartis failed to report side effects of leukemia drug
Fierce Pharma
Mon, 05/12/14 - 11:56 am
Tags:
Tasigna, Novartis, Japan
Allergan CEO says 'rumor mill' inconsistent with company history of discreteness
The Fly on the Wall
Mon, 05/12/14 - 09:48 am
Tags:
Allergan, Pharma CEOs, M&A, JNJ, GSK, Novartis, Valeant Pharmaceuticals
Show me the money: Which drugs made the top 10 list on upfront deals?
Fierce Biotech
Mon, 05/12/14 - 09:36 am
Tags:
biotech, GED-0301, Celgene, Nogra Pharma, AbbVie, Reata, Bardoxolone, Abbott Labs, Tradjenta, Eli Lilly, Boehringer Ingelheim, FG-4592, AstraZeneca, FibroGen, Pfizer, Bristol-Myers Squibb, Eliquis, Moderna, Forma Therapeutics, dimebon, Medivation, Jakafi, Novartis, Incyte
Novartis-backed ImaginAb banks $21M for antibody tech
Fierce Biotech
Fri, 05/9/14 - 10:41 am
Tags:
Novartis, ImaginAb, antibody re-engineering
GlaxoSmithKline: Why Is This Pharmaceutical Giant Stepping Out Of The Cancer Arena?
Seeking Alpha
Fri, 05/9/14 - 08:11 am
Tags:
GSK, cancer, Novartis
10 big brands keep pumping out big bucks, with a little help from price hikes
Fierce Pharma Marketing
Wed, 05/7/14 - 03:42 pm
Tags:
Xyrem, Jazz Pharmaceuticals, Humulin, Eli Lilly, Premarin, Mylan, Lunesta, Sunovion, Benicar, Daiichi Sankyo, Lantus, Sanofi, Viagra, Pfizer, Gleevec, Novartis, Copaxone, Teva Pharmaceuticals, EpiPen, drug pricing
GlaxoSmithKline: Bringing Focus To The Business
Seeking Alpha
Mon, 05/5/14 - 07:53 am
Tags:
GSK, Novartis, restructuring
Novartis - Outstanding Strategic Initiatives Rendering The Sluggish Growth Irrelevant
Seeking Alpha
Sun, 05/4/14 - 11:45 am
Tags:
Novartis
Novartis Earnings: What Investors Need to Know
Motley Fool
Sun, 05/4/14 - 11:41 am
Tags:
Novartis, earnings
Meet Lung Cancer's New Enemy
Motley Fool
Sat, 05/3/14 - 11:31 am
Tags:
Novartis, lung cancer, Zykadia
With Big Pharma mergers in the works, whose SG&A costs look ripe for cutting?
Fierce Pharma Marketing
Wed, 04/30/14 - 01:10 pm
Tags:
layoffs, M&A, Novartis, GSK, Pfizer, AstraZeneca
Novartis Gains U.S. Approval of Lung Cancer Treatment
Bloomberg
Tue, 04/29/14 - 07:45 pm
Tags:
Novartis, FDA, ceritinib, non-small cell lung cancer
Biotech M&A is MIA
TheStreet.com
Mon, 04/28/14 - 10:18 am
Tags:
M&A, biotech, Pfizer, Alnylam, Biogen Idec, Celgene, GSK, Novartis, AstraZeneca, Allergan, Valeant Pharmaceuticals
Novartis: Will Restructuring Prove Fruitful For The Company?
Seeking Alpha
Sat, 04/26/14 - 10:56 am
Tags:
Novartis
Drug innovation: In the recovery room
FT.com
Fri, 04/25/14 - 03:21 pm
Tags:
innovation, Roche, Novartis, GSK, Merck, Bristol-Myers Squibb
Novartis INSTEAD study for Onbrez Breezhaler meets primary objective
Yahoo/Fly on the Wall
Fri, 04/25/14 - 08:14 am
Tags:
Novartis, Onbrez Breezhaler, COPD
GSK's R&D staff hit with trade rumors spurred by Novartis' cancer pact
Fierce Biotech
Thu, 04/24/14 - 08:22 am
Tags:
GSK, R&D, Novartis, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.